Letter to the EditorDifficulties of interpretation of Zaire Ebola Virus PCR results and implication in the field
Section snippets
Funding
This work was supported by Service de Santé des Armées (France).
Competing interests
None.
Ethical approval
Not applicable.
Acknowledgment
We thank Dr Pierre Rollin (CDC) for scientific advice.
References (6)
- et al.
Identification of essential outstanding questions for an adequate European laboratory response to Ebola virus Zaire West Africa 2014
J. Clin. Virol.
(2015) - et al.
Clinical presentation of patients with Ebola virus diseases in Conakry, Guinea
N. Engl. J. Med.
(2015) - et al.
Virus inactivation by nucleic acid extraction reagents
J. Virol. Methods
(2004)
There are more references available in the full text version of this article.
Cited by (13)
Insights from clinical research completed during the west Africa Ebola virus disease epidemic
2017, The Lancet Infectious DiseasesCitation Excerpt :A high AST concentration during the first week of illness was shown to be associated with fatal outcome.63 In the same study, AST correlated with the Ebola virus cycle threshold value during PCR analysis, suggesting it could be used as a surrogate marker of viral load.63 Dyspnoea and tachypnoea were observed frequently in west African patients with EVD.
ReEBOV antigen rapid test kit for ebola
2015, The LancetReEBOV antigen rapid test kit for ebola - Authors' reply
2015, The LancetRapid diagnostics for Ebola in emergency settings
2015, The LancetRapid diagnostic tests versus RT–PCR for Ebola virus infections: a systematic review and meta-analysis
2022, Bulletin of the World Health OrganizationEvaluation of RealStar Reverse Transcription-Polymerase Chain Reaction Kits for Filovirus Detection in the Laboratory and Field
2016, Journal of Infectious Diseases
Copyright © 2015 Elsevier B.V. All rights reserved.